1/22/2026Henlius Gains NMPA Green Light for Phase 1b/2 Trial of HLX701

1/22/2026China Companion Animal Health Market to Reach US$ 3.7B by 2030

1/22/2026Hua Medicine Targets Global Diabetes Growth with Non-GLP-1 Strategy

1/22/2026Corxel Raises Up to $287M to Push GLP-1 Pill Toward Global Markets

1/22/2026China Unveils New Policy to Transform Pharmacies into Community Health...

1/22/2026CDE Seeks Public Input on Draft Guidance for Risk Assessment and Contr...

1/22/2026NMPA Issues New Guidance to Standardize Vaccine Adjuvant Research, Boo...

1/22/2026Bangshun Pharma Files for Hong Kong IPO

1/22/2026Genmab Halts Development of Three China-Originated Oncology Assets fro...

1/22/2026T-MAXIMUM Unveils First Human Data for CRISPR-Edited CAR-T

1/22/2026Daiichi Sankyo Wins New China Approval for Enhertu

1/22/2026AbbVie Secures China Approval for Skyrizi in Ulcerative Colitis

1/22/2026Juncell Unveils Phase I TIL Data for Advanced NSCLC as IPO Push Accele...

1/21/2026China Launches Clinical Trial of First Acne Vaccine Candidate

1/21/2026Pomdoctor Deepens Pharma Partnerships to Drive Internet Hospital Expan...

1/21/2026CDE Issues Draft Guidance on Using Bayesian External Data in Drug Clin...

1/21/2026Roche Advances Oral GLP-1 Program as RO7795081 Cleared for China Clini...

1/21/2026Pfizer Pulls Back on Mesothelin-Targeting ADC Sublicensed from Harbour...

1/21/2026NewDEL Raises A+ Round Led by XtalPi to Accelerate DEL-AI Drug Develop...

1/21/2026Telix Advances China Strategy as Prostate Cancer Imaging Filing Clears...

1/21/2026Harbour BioMed Takes Strategic Stake in Spruce Biosciences

1/20/2026Hybio Wins CNY 180M GLP-1 API Order as Novo Nordisk Seen as Likely Cus...

1/20/2026Ellipses In-Licenses First-in-Class B7H3 ADC from China's Innolake

1/20/2026Insilico and Hygtia Therapeutics Forge Global Alliance on AI-Discovere...

1/20/2026GSK to Buy RAPT Thera for $2.2B, Securing China-Partnered Anti-IgE Ass...

1/19/2026NMPA Announces Adoption of ICH Q8/Q9/Q10 Q&A (R5) Guidelines for Drug ...

1/19/2026Biyo Secures ~CNY 100M in Pre-A Funding as Lead Migraine Biologic Adva...

1/19/2026ABM Thera Licenses MEK1/2 Inhibitor ABM-168 to Mosaica Medicines for G...

1/19/2026Henlius Biotech Secures Global Rights to IL-1RAP Antibody from U-mab B...

1/19/2026AstraZeneca Acquires Full Global Rights to AbelZeta’s GPC3 Armored CA...

Page:1/59 Total number of articles:1742: [First][<<] [1] [2] [3] [4] [5] [>>] [End]